Deep Lung Deposition
Deep Lung Deposition is a pharmacokinetic process denoting the deposition of inhaled aerosolized drug particles specifically within the alveolar and small airway regions of the lungs, distinguished from upper airway deposition by particle size, inhalation dynamics, and targeted therapeutic intent.
68
Publications
2.8K
Citations
327
Authors
128
Institutions
Publications per year
2017–2026
29
Parents
68
Wolfgang G. Kreyling, Manuela Semmler‐Behnke, Jürgen Seitz et al. · Inhalation Toxicology · 2009 · 384 citations
Pharmacy, Pharmacology, Toxicology +17
Unveiling the Molecular Structure of Pulmonary Surfactant Corona on Nanoparticles
Qinglin Hu, Xuan Bai, Guoqing Hu et al. · ACS Nano · 2017 · 125 citations · Full text
Pantelis Koullapis, Philipp Hofemeier, Josué Sznitman et al. · European Journal of Pharmaceutical Sciences · 2017 · 87 citations
1–5 of 68
327
3
h-index
3
h-index
3
h-index
3
h-index
3
h-index
1–5 of 327
128
Harvard–MIT Division of Health Sciences and Technology
Cambridge, United States
3 h-index
5 publications
338 citations
Mental Research Institute
Palo Alto, United States
3 h-index
13 publications
177 citations
Harvard University
Cambridge, United States
3 h-index
5 publications
338 citations

Brigham and Women's Hospital
Boston, United States
3 h-index
5 publications
338 citations
Damanhour University
Damanhur, Egypt
3 h-index
4 publications
249 citations
RMIT University
Melbourne, Australia
3 h-index
11 publications
441 citations

Alexandria University
Alexandria, Egypt
3 h-index
19 publications
1.3K citations
University of Cyprus
Nicosia, Cyprus
2 h-index
5 publications
414 citations
1–8 of 128
3 publications · 58 citations
3
h-index
3 publications · 96 citations
3
h-index
3 publications · 41 citations
3
h-index
3 publications · 75 citations
3
h-index
2 publications · 67 citations
2
h-index
1–5